SCHEMBL15835664

SCHEMBL15835664

C=CCc1c(O)ccc2c(CCC)c(O)ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.41
XDH P47989 1/20 0.39
MTNR1A P48039 1/20 0.39
GABRA1 P14867 4/20 0.38
GABRB2 P47870 4/20 0.38
ALDH1A1 P00352 2/20 0.38
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
MEN1 O00255 1/20 0.38
ALDH2 P05091 1/20 0.38
MAPT P10636 1/20 0.38
AKR1B1 P15121 1/20 0.38
HPGD P15428 1/20 0.38
PPARG P37231 1/20 0.38
KMT2A Q03164 1/20 0.38
PPARD Q03181 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6398012 0.87 SRD5A1 (0.49) SRD5A1XDHMTNR1AGABRA1GABRB2
SCHEMBL17024157 0.79 ALDH1A1 (0.41) SRD5A1XDHMTNR1AGABRA1GABRB2
SCHEMBL323547 0.76 XDH (0.54) SRD5A1XDHMTNR1AGABRA1GABRB2
SCHEMBL11667176 0.75 CYP19A1 (0.50) SRD5A1XDHMTNR1AALDH1A1KDM4E
SCHEMBL28274016 0.75 SRD5A1 (0.46) SRD5A1XDHMTNR1AGABRA1GABRB2
SCHEMBL8042761 0.74 GABRA1 (0.39) SRD5A1XDHMTNR1AGABRA1GABRB2
Hydrogen Sulfide SCHEMBL6721312 0.74 XDH (0.52) SRD5A1XDHMTNR1AGABRA1GABRB2
SCHEMBL9027584 0.74 MTNR1A (0.46) SRD5A1MTNR1AGABRA1GABRB2ALDH1A1
SCHEMBL1743958 0.74 PRKCI (0.44) SRD5A1XDHMTNR1AGABRA1GABRB2
SCHEMBL1760417 0.73 CNR1 (0.50) ALDH1A1CNR1CNR2KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140179836-A1 EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD OF PREPARING THE SAME, COMPOSITION AND CURED PRODUCT COMPRISING THE SAME, AND USES THEREOF KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2014-06-26 US disclosed
US-20140179836-A1 EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD OF PREPARING THE SAME, COMPOSITION AND CURED PRODUCT COMPRISING THE SAME, AND USES THEREOF KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2014-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179836-A1 EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD OF PREPARING THE SAME, COMPOSITION AND CURED PRODUCT COMPRISING THE SAME, AND USES THEREOF PFAS, FAR1, ELOVL1 SRD5A1 1604/4885XDH 4809/4885MTNR1A 4295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.